Robust immune responses are observed after one dose of BNT162b2 mRNA vaccine dose in SARS-CoV-2 experienced individuals

The use of COVID-19 vaccines will play the major role in helping to end the pandemic that has killed millions worldwide. COVID-19 vaccines have resulted in robust humoral responses and protective efficacy in human trials, but efficacy trials excluded individuals with a prior diagnosis of COVID-19. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Samanovic, Marie I., Cornelius, Amber R., Gray-Gaillard, Sophie L., Allen, Joseph Richard, Karmacharya, Trishala, Wilson, Jimmy P., Wesley Hyman, Sara, Tuen, Michael, Koralov, Sergei B., Mulligan, Mark J., Sedaghat Herati, Ramin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248013/
https://www.ncbi.nlm.nih.gov/pubmed/34874183
http://dx.doi.org/10.1126/scitranslmed.abi8961

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9248013/
https://www.ncbi.nlm.nih.gov/pubmed/34874183
http://dx.doi.org/10.1126/scitranslmed.abi8961

Ejemplares similares